ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

BTMD Biote Corporation

5.32
-0.13 (-2.39%)
After Hours
Last Updated: 21:30:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Biote Corporation NASDAQ:BTMD NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.13 -2.39% 5.32 5.30 5.34 5.47 5.305 5.46 46,921 21:30:00

BioTech Medics, Inc. Answers Lawsuit and Files Counterclaim

11/01/2006 7:28pm

PR Newswire (US)


Biote (NASDAQ:BTMD)
Historical Stock Chart


From Oct 2019 to Oct 2024

Click Here for more Biote Charts.
DALLAS, Jan. 11 /PRNewswire-FirstCall/ -- BioTech Medics, Inc. (OTC Pink Sheets: BTMD) announced that the company, as Defendant, had been served with a Texas civil defamation action by Adam Barnett, a Florida resident, as Plaintiff. BioTech has vigorously denied Barnett's allegations and filed a counterclaim against him, and has also filed a third-party petition against William Seminario, a Florida resident, and Hamilton Holdings PA Corp., a Pennsylvania corporation. BioTech's counterclaim and third party petition alleges that Barnett, Seminario and Hamilton conspired to unlawfully deprive BioTech of over 12 Million shares of its common stock and manipulated the value of BioTech's common stock. BioTech further alleges in its counterclaim against Barnett that Barnett, using a series of aliases, published false and defamatory statements against BioTech and its management, using the Internet. Keith Houser, CEO of BioTech, stated "We will aggressively pursue this litigation until its conclusion. We have also been in contact with the Securities and Exchange Commission-Enforcement Division about our allegations and intend to continue to assist the SEC in their investigation in any way we can." Source: BioTech Medics, Inc. Contact: Keith Houser, CEO 972-849-2772 Safe Harbor for Forward-Looking Statements. This press release may contain forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995 (the "Act"). In Particular, when used in the preceding discussion, the words "plan," "confident that," "believe," "scheduled," "expect," or "intend to," and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. DATASOURCE: BioTech Medics, Inc. CONTACT: Keith Houser, CEO of BioTech Medics, Inc., +1-972-849-2772 Web site: http://www.biotechmedics.com/

Copyright

1 Year Biote Chart

1 Year Biote Chart

1 Month Biote Chart

1 Month Biote Chart

Your Recent History

Delayed Upgrade Clock